Mutations (point, frameshift) Knowledge-Based Study

Study notes

1. What Is a Gene Mutation?

   A gene mutation is a permanent alteration in the nucleotide sequence of DNA that makes up a gene. During gene expression, the genetic code stored in DNA is transcribed into messenger RNA (mRNA) and then translated into a polypeptide chain according to specific nucleotide triplets called codons.

   Because the sequence of codons dictates the precise order of amino acids in a protein, alterations at the nucleotide level can directly modify protein structure and function. Gene mutations generally fall into two primary structural categories based on how they alter the nucleotide sequence:

   • Point mutations (base-pair substitutions): Changes involving a single nucleotide base pair.
   • Frameshift mutations (insertions or deletions): Additions or losses of nucleotide pairs that disrupt the triplet reading frame.

   Mechanisms of Point Mutations

   A point mutation occurs when one nucleotide base pair in the DNA molecule is replaced by a different base pair. Because the genetic code is read in discrete sets of three nucleotides, a substitution alters only the specific codon in which it occurs.

   Functional Consequences of Point Mutations

   Due to the redundancy (degeneracy) of the genetic code, base substitutions result in one of three functional outcomes:

   • Silent Mutation: The substituted nucleotide alters a codon, but the new codon codes for the exact same amino acid. As a result, the primary structure of the polypeptide remains unchanged, producing a fully functional protein.
   • Missense Mutation: The nucleotide change results in a codon that codes for a different amino acid. The effect on the protein varies; it may be harmless if the new amino acid has similar chemical properties, or it may drastically alter folding and function, as seen in sickle cell disease (where a GAG-to-GTG change replaces glutamic acid with valine).
   • Nonsense Mutation: The base substitution changes an amino acid-specifying codon into a premature stop codon (UAA, UAG, or UGA in mRNA). Translation terminates prematurely, yielding a truncated, usually nonfunctional polypeptide.

   Insertions, Deletions, and the Triplet Code

   During translation, ribosomes read mRNA linearly in non-overlapping triplets known as the reading frame. A frameshift mutation occurs when one or more nucleotide pairs are inserted or deleted from the coding sequence in numbers that are not multiples of three.

   Downstream Consequences

   Because the ribosome groups nucleotides strictly in threes from the start codon onward, an insertion or deletion shifts the grouping of all subsequent nucleotides:

   • Extensive Missense: Every codon downstream of the mutation site is misread, resulting in an entirely incorrect sequence of amino acids from that point forward.
   • Premature Termination: Shifting the reading frame frequently generates an unintended stop codon shortly downstream, causing premature termination of translation.
   • Critical Loss of Function: Because the overall amino acid composition and length of the polypeptide are severely modified, proteins produced from frameshift alleles almost always lose biological activity completely.

   Note: If exactly three nucleotides (or a multiple of three) are inserted or deleted, the reading frame is preserved downstream; instead, one or more amino acids are simply added or removed from the final polypeptide.

   Summary of Mutational Impacts

   The severity of a mutation depends heavily on where it occurs and how it impacts the translational reading frame:

   • Point mutations are localized to a single codon. Their impact ranges from completely neutral (silent) to moderate (missense) or severe (nonsense).
   • Frameshift mutations alter the reading frame for all downstream codons, typically leading to extensive structural failure or complete loss of function.

   Understanding these mechanisms explains how minute alterations at the molecular level of DNA can yield profound phenotypic variations and genetic disorders in living organisms.